News|Articles|April 28, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

  • PTSM: Pharmaceutical Technology Sourcing and Management-05-07-2014
  • Volume 10
  • Issue 5

Sartorius Stedim Biotech Acquires Majority Stake in AllPure Technologies

Sartorius Stedim Biotech's acquisition of AllPure Technologies will extends its portfolio for single-use bioprocessing.

Sartorius Stedim Biotech has signed a contract to acquire the majority stake in the US start-up, AllPure Technologies LLC. The privately owned company based in New Oxford, PA, has been in operation for four years, and earned revenue of approximately $3 million in 2013 with 25 employees. AllPure specializes in single-use components for biopharmaceutical applications, such as aseptic sampling techniques. The parties agreed not to disclose any further details of the purchase agreement.

Source: Sartorius Stedim Biotech

Articles in this issue

almost 12 years ago

Using eClinical Systems for Supply-Chain Management

almost 12 years ago

Janssen Pharmaceutical Collaborates with Stiching International Dispensary Association

almost 12 years ago

FDA and Industry Take Action for a More Secure Drug Supply Chain

almost 12 years ago

Packaging Becomes Enabler for Biopharmaceuticals

almost 12 years ago

Bristol-Myers Squibb Named First on 2014 Best Corporate Citizens List

almost 12 years ago

Azzur Group and BioSPEQ Announce Merger

almost 12 years ago

Eli Lilly Launches Second Education Program for Medical Students

almost 12 years ago

Global Instability Impacts Brazil's Pharma Market

almost 12 years ago

US Biopharma Worries About Losing Lead in Innovation

almost 12 years ago

Outsourcing Remains Strong In Traditional Areas

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content